Sharma, Dolly
Xing, Shan
Hung, Yu-Ting
Caskey, Rachel N.
Dowell, Maria L.
Touchette, Daniel R.
Article History
Received: 4 July 2018
Accepted: 12 September 2018
First Online: 29 September 2018
Authors’ information
: DRT, PharmD, MA, FCCP, is Full Professor and Takeda Professor in Medication Adherence in the Department of Pharmacy Systems, Outcomes and Policy in the UIC College of Pharmacy. He is an IHRP Fellow and has been a core faculty member of the UIC Center for Pharmacoepidemiology and Pharmacoeconomic Research since August 2005 and an Assistant Director since 2016. He has vast experience of conducting cost-effectiveness analysis for various types of interventions.MLD, MD, is an Associate Professor of Medicine and Pediatrics and Associate Director, Pediatric Cystic Fibrosis Center at the University of Chicago. She specializes in pulmonary medicine and provides care for adults and children with a range of respiratory disorders, including cystic fibrosis, complex asthma and chronic lung disease.RNC, MD, MAPP is the Division Chief of Academic Internal Medicine and Geriatrics and Associate Professor of Medicine and a health services researcher at UIC College of medicine. She also holds an affiliate appointment at UIC’s School of Public Health.
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.